This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kirchmair, R. Articles by Schratzberger, P. Search for Related Content PubMed PubMed Citation Articles by Kirchmair, R. Articles by Schratzberger, P. Related Collections Angiogenesis Other Vascular biology

(Circulation. 2004;109:777-783.)
© 2004 American Heart Association, Inc.

Basic Science Reports

The Neuropeptide Secretoneurin Acts as a Direct Angiogenic Cytokine In Vitro and In Vivo

Rudolf Kirchmair, MD; Roland Gander, PhD; Margot Egger; Allison Hanley; Marcy Silver; Andreas Ritsch, PhD; Toshinori Murayama, MD, PhD; Nicole Kaneider, MD; Wolfgang Sturm, MD; Marianne Kearny; Reiner Fischer-Colbrie, PhD; Brigitte Kircher, PhD; Hannes Gaenzer, MD; Christian J. Wiedermann, MD; Allan H. Ropper, MD; Douglas W. Losordo, MD; Josef R. Patsch, MD; Peter Schratzberger, MD

From the Departments of Internal Medicine (R.K., R.G., M.E., A.R., N.K., W.S., B.K., H.G., C.J.W., J.R.P., P.S) and Pharmacology (R.F.C.), University of Innsbruck, Austria, and Departments of Cardiovascular Research (A.H., M.S., T.M., M.K., D.W.L.), Vascular Medicine (D.W.L.), and Neurology (A.H.R.), St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, Mass.

Correspondence to Peter Schratzberger, MD, Department of Internal Medicine, University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria. E-mail peter.schratzberger{at}uibk.ac.at

Received March 18, 2003; de novo received July 9, 2003; revision received October 3, 2003; accepted October 6, 2003.

Background— Secretoneurin is an abundant neuropeptide of the central, peripheral, and autonomic nervous systems, located in nerve fibers characterized by a close interaction with blood vessels and known to stimulate endothelial cell migration.

Methods and Results— We hypothesized that secretoneurin might act as an angiogenic cytokine and tested for these effects in vivo using a mouse cornea neovascularization model and in vitro by assessing capillary tube formation in a matrigel assay. In vivo, secretoneurin-induced neovasculature is characterized by a distinct pattern of arterial and venous vessels of large diameter and length. Immunohistochemical staining for CD-31 revealed endothelial lining of the inner surface of these vessels, and recruitment of -smooth muscle actin–positive perivascular cells suggests vessel maturation. In vitro, secretoneurin-induced capillary tube formation was dose dependent and specific, confirming that effects of secretoneurin occur directly on endothelial cells. Secretoneurin also stimulated proliferation and exerted antiapoptotic effects on endothelial cells and activated intracellular phosphatidylinositol 3' kinase/Akt and mitogen-activated protein kinase pathways, as demonstrated by increased phosphorylation of Akt and extracellular signal–regulated kinase.

Conclusions— These data show that secretoneurin represents a novel direct angiogenic cytokine and reiterate the coordinated relationship between nervous and vascular systems.

Key Words: angiogenesis • endothelium • nervous system

This article has been cited by other articles:

				M. Courel, M. S. Vasquez, V. Y. Hook, S. K. Mahata, and L. Taupenot Sorting of the Neuroendocrine Secretory Protein Secretogranin II into the Regulated Secretory Pathway: ROLE OF N- AND C-TERMINAL {alpha}-HELICAL DOMAINS J. Biol. Chem., April 25, 2008; 283(17): 11807 - 11822. [Abstract] [Full Text] [PDF]

				M. Egger, W. Schgoer, A. G. E. Beer, J. Jeschke, J. Leierer, M. Theurl, S. Frauscher, O. M. Tepper, A. Niederwanger, A. Ritsch, et al. Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1{alpha}- and basic FGF-dependent pathway in muscle cells FASEB J, September 1, 2007; 21(11): 2906 - 2917. [Abstract] [Full Text] [PDF]

				G. Wen, J. Wessel, W. Zhou, G. B. Ehret, F. Rao, M. Stridsberg, S. K. Mahata, P. M. Gent, M. Das, R. S. Cooper, et al. An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension Hum. Mol. Genet., July 15, 2007; 16(14): 1752 - 1764. [Abstract] [Full Text] [PDF]

				J. Troger, A. Doblinger, J. Leierer, A. Laslop, E. Schmid, B. Teuchner, M. Opatril, W. Philipp, L. Klimaschewski, K. Pfaller, et al. Secretoneurin in the Peripheral Ocular Innervation Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 647 - 654. [Abstract] [Full Text] [PDF]

				R. Kirchmair, M. Egger, D. H. Walter, W. Eisterer, A. Niederwanger, E. Woell, M. Nagl, M. Pedrini, T. Murayama, S. Frauscher, et al. Secretoneurin, an Angiogenic Neuropeptide, Induces Postnatal Vasculogenesis Circulation, August 31, 2004; 110(9): 1121 - 1127. [Abstract] [Full Text] [PDF]